SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-017681
Filing Date
2024-06-20
Accepted
2024-06-20 16:50:17
Documents
2
Period of Report
2024-06-17

Document Format Files

Seq Description Document Type Size
1 form4-06202024_080614.html 4  
1 form4-06202024_080614.xml 4 4426
2 ex24-06202024_080621.htm EX-24 6597
  Complete submission text file 0001415889-24-017681.txt   12568
Mailing Address 100 CARDINAL WAY REDWOOD CITY CA 94063
Business Address 100 CARDINAL WAY REDWOOD CITY CA 94063 (650) 649-1004
Adverum Biotechnologies, Inc. (Issuer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O AKOUOS, INC. 645 SUMMER STREET SUITE 200 BOSTON MA 02210
Business Address
Ozden Rabia Gurses (Reporting) CIK: 0001814883 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36579 | Film No.: 241057184